切换至 "中华医学电子期刊资源库"

中华关节外科杂志(电子版) ›› 2025, Vol. 19 ›› Issue (06) : 708 -713. doi: 10.3877/cma.j.issn.1674-134X.2025.06.009

综述

中医药治疗类风湿关节炎的药效机制研究
麻凌峰1, 张小杉1, 魏颖2, 张敏洁1, 于超1, 王雅晳1,()   
  1. 1010050 呼和浩特,内蒙古医科大学附属医院超声科
    2010050 呼和浩特,内蒙古医科大学附属医院临床医学研究中心(医学细胞生物学重点实验室/工程实验室)
  • 收稿日期:2024-11-23 出版日期:2025-12-01
  • 通信作者: 王雅晳
  • 基金资助:
    内蒙古自治区自然科学基金项目(2024MS08066); 内蒙古医科大学附属医院博士科研启动金项目(2022NYFYBS011); 内蒙古医科大学重点项目(YKD2024ZD003)

Study progress in pharmacodynamic mechanism of Chinese medicine on rheumatoid arthritis

Lingfeng Ma1, Xiaoshan Zhang1, Ying Wei2, Minjie Zhang1, Chao Yu1, Yaxi Wang1,()   

  1. 1Department of Ultrasound, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China
    2Clinical Medical Research Center of the Affiliated Hospital/Autonomous Region Key Laboratory of Medical Cell Biology, Inner Mongolia Medical University, Hohhot 010050, China
  • Received:2024-11-23 Published:2025-12-01
  • Corresponding author: Yaxi Wang
引用本文:

麻凌峰, 张小杉, 魏颖, 张敏洁, 于超, 王雅晳. 中医药治疗类风湿关节炎的药效机制研究[J/OL]. 中华关节外科杂志(电子版), 2025, 19(06): 708-713.

Lingfeng Ma, Xiaoshan Zhang, Ying Wei, Minjie Zhang, Chao Yu, Yaxi Wang. Study progress in pharmacodynamic mechanism of Chinese medicine on rheumatoid arthritis[J/OL]. Chinese Journal of Joint Surgery(Electronic Edition), 2025, 19(06): 708-713.

类风湿关节炎(RA)是一种影响外周小关节的自身免疫性疾病,主要病变包括炎症反应、滑膜细胞增殖及滑膜血管新生。中医认为,"湿、热、瘀"是RA的首要病机理论。中药复方制剂及主要活性化合物,主要通过抑制炎性作用和成纤维样滑膜细胞(FLS)增殖,起到抗RA作用,同时也可以通过抑制滑膜血管生成,阻止RA病情恶化。因此,探讨更多中药复方制剂及主要活性化合物对RA血管新生的药效机制,在未来具有一定的研究潜力。本文旨在探究具有"温经散寒"和"祛风除湿"功效的中药复方制剂及主要活性成分,为它们通过抗炎、抗FLS增殖和抗血管生成途径治疗RA提供理论依据。

Rheumatoid arthritis (RA) is an autoimmune disease that involves the small peripheral joints, and the main lesions include inflammatory reaction, synovial cell proliferation and synovial neovascularization. According to Chinese medicine, "dampness, heat and stasis" are the main theories of RA’s pathogenesis. Chinese medicine compound preparation and its main active ingredients can inhibit the inflammatory reaction, the proliferation of fibroblast-like synoviocytes (FLS), and synovial blood vessel neovascularization, thus preventing the deterioration of RA. Therefore, it is promising to explore the pharmacodynamic mechanism of Chinese medicine compound preparation and its main active ingredients on RA angiogenesis. This article aimed to investigate traditional Chinese medicine compound formulations with "warming the meridians and dispelling cold" and "dispelling wind and dampness" effects, along with their primary active components, to provide a theoretical basis for their therapeutic application in RA through anti-inflammatory, anti-FLS proliferation, and anti-angiogenic pathways.

[1]
《中成药治疗优势病种临床应用指南》标准化项目组, 姜泉, 赵岩. 中成药治疗类风湿关节炎临床应用指南(2022年)[J]. 中国中西医结合杂志, 2023, 43(3): 261-273.
[2]
Lee DM, Weinblatt ME. Rheumatoid arthritis[J]. Lancet, 2001, 358(9285): 903-911.
[3]
Li Y, Ding T, Chen J, et al. The protective capability of Hedyotis diffusa Willd on lupus nephritis by attenuating the IL-17 expression in MRL/lpr mice[J/OL]. Front Immunol, 2022, 13: 943827. DOI: 10.3389/fimmu.2022.943827.
[4]
Hao W, Chen Z, Yuan Q, et al. Ginger polysaccharides relieve ulcerative colitis via maintaining intestinal barrier integrity and gut microbiota modulation[J]. Int J Biol Macromol, 2022, 219: 730-739.
[5]
Wang J, Chen S, Zhang J, et al. Scutellaria baicalensis Georgi is a promising candidate for the treatment of autoimmune diseases[J/OL]. Front Pharmacol, 2022, 13: 946030. DOI: 10.3389/fphar.2022.946030.
[6]
Wang Y, Chen S, Du K, et al. Traditional herbal medicine: Therapeutic potential in rheumatoid arthritis[J/OL]. J Ethnopharmacol, 2021, 279: 114368. DOI: 10.1016/j.jep.2021.114368.
[7]
黄帝内经素问[M]. 北京: 人民卫生出版社, 1963: 197.
[8]
刘蔚翔, 姜泉. 中西医治疗类风湿关节炎的研究进展[J]. 中华中医药杂志, 2022, 37(12): 7251-7257.
[9]
刘蔚翔, 姜泉. 类风湿关节炎"湿、热、瘀"病机理论探析[J]. 中医杂志, 2020, 61(24): 2148-2153.
[10]
赵越, 晏菁遥, 黄闰月, 等. 近十年治疗类风湿关节炎文献的中医证候分布与遣方用药规律分析[J]. 中华中医药学刊, 2019, 37(9): 2168-2177.
[11]
王建, 巩勋, 唐晓颇, 等. 1602例类风湿关节炎患者中医证候分布特点的多中心横断面调查[J]. 中医杂志, 2018, 59(11): 963-967.
[12]
曹玉举. 娄多峰"虚、邪、瘀"理论论治类风湿关节炎[J]. 中华中医药杂志, 2018, 33(2): 569-571.
[13]
Chen Z, Bozec A, Ramming A, et al. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis[J]. Nat Rev Rheumatol, 2019, 15(1): 9-17.
[14]
刘蔚翔, 巩勋, 姜泉, 等. 类风湿关节炎湿热与寒湿证候的病情特点分析[J]. 中华中医药杂志, 2021, 36(2): 1088-1091.
[15]
Tu J, Hong W, Zhang P, et al. Ontology and function of fibroblast-like and macrophage-like synoviocytes: how do they talk to each other and can they be targeted for rheumatoid arthritis therapy?[J/OL]. Front Immunol, 2018, 9: 1467. DOI: 10.3389/fimmu.2018.01467.
[16]
Wang Y, Wu H, Deng R. Angiogenesis as a potential treatment strategy for rheumatoid arthritis[J/OL]. Eur J Pharmacol, 2021, 910: 174500. DOI: 10.1016/j.ejphar.2021.174500.
[17]
Yu L, Li S, Pu L, et al. Traditional Tibetan medicine: therapeutic potential in rheumatoid arthritis[J/OL]. Front Pharmacol, 2022, 13: 938915. DOI: 10.3389/fphar.2022.938915.
[18]
Li XZ, Zhang SN. Recent advance in treatment of osteoarthritis by bioactive components from herbal medicine[J/OL]. Chin Med, 2020, 15: 80. DOI: 10.1186/s13020-020-00363-5.
[19]
Li XZ, Zhang SN. Herbal compounds for rheumatoid arthritis: Literatures review and cheminformatics prediction[J]. Phytother Res, 2020, 34(1): 51-66.
[20]
Lu C, Cheng RJ, Zhang Q, et al. Herbal compound cepharanthine attenuates inflammatory arthritis by blocking macrophage M1 polarization[J/OL]. Int Immunopharmacol, 2023, 125(Pt B): 111175. DOI: 10.1016/j.intimp.2023.111175.
[21]
de Seabra Rodrigues Dias IR, Lo HH, Zhang K, et al. Potential therapeutic compounds from traditional Chinese medicine targeting endoplasmic reticulum stress to alleviate rheumatoid arthritis[J/OL]. Pharmacol Res, 2021, 170: 105696. DOI: 10.1016/j.phrs.2021.105696.
[22]
Zhang H, Liu J, Zhang P, et al. Herbal formula longteng decoction promotes the regression of synovial inflammation in collagen-induced arthritis mice by regulating type 2 innate lymphocytes[J/OL]. Front Pharmacol, 2021, 12: 778845. DOI: 10.3389/fphar.2021.778845.
[23]
Hu N, Wang C, Wang B, et al. Qianghuo Shengshi decoction exerts anti-inflammatory and analgesic via MAPKs/CREB signaling pathway[J/OL]. J Ethnopharmacol, 2022, 284: 114776. DOI: 10.1016/j.jep.2021.114776.
[24]
Wang T, Jia Q, Chen T, et al. Alleviation of synovial inflammation of juanbi-Tang on collagen-induced arthritis and TNF-tg mice model[J/OL]. Front Pharmacol, 2020, 11: 45. DOI: 10.3389/fphar.2020.00045.
[25]
Li D, Liu W, Sun S, et al. Chinese herbal formula, modified Xianfang Huoming Yin, alleviates the inflammatory proliferation of rat synoviocytes induced by IL-1β through regulating the migration and differentiation of T lymphocytes[J/OL]. J Ethnopharmacol, 2023, 309: 116297. DOI: 10.1016/j.jep.2023.116297.
[26]
岳静, 王世军. 薏苡仁及其组分对佐剂性关节炎大鼠抗炎镇痛的作用及其机制[J]. 中国组织工程研究, 2023, 27(26): 4187-4192.
[27]
Xu Q, Kong H, Ren S, et al. Coix seed oil alleviates synovial angiogenesis through suppressing HIF-1α/VEGF-A signaling pathways via SIRT1 in collagen-induced arthritis rats[J/OL]. Chin Med, 2023, 18(1): 119. DOI: 10.1186/s13020-023-00833-6.
[28]
戎嘉诚, 洪俊, 黄磊, 等. 基于网络药理学和分子对接法分析5种中药活性成分治疗心肌缺血再灌注损伤的机制[J]. 辽宁中医杂志, 2024, 51(6): 5-10, 223-225.
[29]
Li S, Huang X, Li Y, et al. Spectrum-effect relationship in Chinese herbal medicine: current status and future perspectives[J]. Crit Rev Anal Chem, 2025, 55(2): 353-374.
[30]
Jo S, Samarpita S, Lee JS, et al. 8-Shogaol inhibits rheumatoid arthritis through targeting TAK1[J/OL]. Pharmacol Res, 2022, 178: 106176. DOI: 10.1016/j.phrs.2022.106176.
[31]
Liu X, Wang Z, Qian H, et al. Natural medicines of targeted rheumatoid arthritis and its action mechanism[J/OL]. Front Immunol, 2022, 13: 945129. DOI: 10.3389/fimmu.2022.945129.
[32]
Rufino AT, Freitas M, Proença C, et al. Rheumatoid arthritis molecular targets and their importance to flavonoid-based therapy[J]. Med Res Rev, 2024, 44(2): 497-538.
[33]
Shen P, Lin W, Deng X, et al. Potential implications of quercetin in autoimmune diseases[J/OL]. Front Immunol, 2021, 12: 689044. DOI: 10.3389/fimmu.2021.689044.
[34]
张广辉, 魏琴, 李坤, 等. 基于Wnt3a/β-catenin通路探讨马钱子总生物碱对类风湿关节炎大鼠滑膜细胞凋亡的影响[J]. 现代免疫学, 2025, 45(5): 511-518.
[35]
Yan Y, Zhang LB, Ma R, et al. Jolkinolide B ameliorates rheumatoid arthritis by regulating the JAK2/STAT3 signaling pathway[J/OL]. Phytomedicine, 2024, 124: 155311. DOI: 10.1016/j.phymed.2023.155311.
[36]
Shirai T, Nakai A, Ando E, et al. Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complex[J/OL]. Sci Immunol, 2023, 8(81): eadc9324. DOI: 10.1126/sciimmunol.adc9324.
[37]
Correa LB, Almeida Pádua T, Alabarse PVG, et al. Protective effect of methyl gallate on murine antigen-induced arthritis by inhibiting inflammatory process and bone erosion[J]. Inflammopharmacology, 2022, 30(1): 251-266.
[38]
Shen Y, Teng L, Qu Y, et al. Anti-proliferation and anti-inflammation effects of corilagin in rheumatoid arthritis by downregulating NF-κB and MAPK signaling pathways[J/OL]. J Ethnopharmacol, 2022, 284: 114791. DOI: 10.1016/j.jep.2021.114791.
[39]
Bischoff-Kont I, Primke T, Niebergall LS, et al. Ginger constituent 6-shogaol inhibits inflammation- and angiogenesis-related cell functions in primary human endothelial cells[J/OL]. Front Pharmacol, 2022, 13: 844767. DOI: 10.3389/fphar.2022.844767.
[40]
Nazari-Khanamiri F, Ghasemnejad-Berenji M. Resveratrol may ameliorate rheumatoid arthritis via the STAT3/HIF-1/VEGF molecular pathway[J/OL]. J Food Biochem, 2022, 46(8): e14182. DOI: 10.1111/jfbc.14182.
[41]
Tao Y, Liu J, Li M, et al. Abelmoschus manihot (L. ) medik. seeds alleviate rheumatoid arthritis by modulating JAK2/STAT3 signaling pathway[J/OL]. J Ethnopharmacol, 2024, 325: 117641. DOI: 10.1016/j.jep.2023.117641.
[42]
Zhan H, Chen R, Zhong M, et al. Exploring the pharmacological mechanisms and key active ingredients of total flavonoids from Lamiophlomis rotata (Benth. ) Kudo against rheumatoid arthritis based on multi-technology integrated network pharmacology[J/OL]. J Ethnopharmacol, 2023, 317: 116850. DOI: 10.1016/j.jep.2023.116850.
[43]
Sun YW, Bao Y, Yu H, et al. Anti-rheumatoid arthritis effects of flavonoids from Daphne genkwa[J/OL]. Int Immunopharmacol, 2020, 83: 106384. DOI: 10.1016/j.intimp.2020.106384.
[44]
Wu JY, Chen YJ, Fu XQ, et al. Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling[J/OL]. BMC Complement Med Ther, 2022, 22(1): 73. DOI: 10.1186/s12906-022-03553-w.
[45]
Zhang L, Wei W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony[J/OL]. Pharmacol Ther, 2020, 207: 107452. DOI: 10.1016/j.pharmthera.2019.107452.
[46]
Bu Y, Wu H, Deng R, et al. The anti-angiogenesis mechanism of Geniposide on rheumatoid arthritis is related to the regulation of PTEN[J]. Inflammopharmacology, 2022, 30(3): 1047-1062.
[47]
Luo S, Li H, Liu J, et al. Andrographolide ameliorates oxidative stress, inflammation and histological outcome in complete Freund’s adjuvant-induced arthritis[J/OL]. Chem Biol Interact, 2020, 319: 108984. DOI: 10.1016/j.cbi.2020.108984.
[48]
Meng M, Yue Z, Chang L, et al. Anti-rheumatoid arthritic effects of Paris saponin VII in human rheumatoid arthritis fibroblast-like synoviocytes and adjuvant-induced arthritis in rats[J/OL]. Front Pharmacol, 2021, 12: 683698. DOI: 10.3389/fphar.2021.683698.
[49]
Meng N, Xie HX, Hou JR, et al. Design and semisynthesis of oleanolic acid derivatives as VEGF inhibitors: Inhibition of VEGF-induced proliferation, angiogenesis, and VEGFR2 activation in HUVECs[J]. Chin J Nat Med, 2022, 20(3): 229-240.
[50]
Li Z, Chen M, Wang Z, et al. Berberine inhibits RA-FLS cell proliferation and adhesion by regulating RAS/MAPK/FOXO/HIF-1 signal pathway in the treatment of rheumatoid arthritis[J]. Bone Joint Res, 2023, 12(2): 91-102.
[51]
Cai J, Zhang LC, Zhao RJ, et al. Chelerythrine ameliorates rheumatoid arthritis by modulating the AMPK/mTOR/ULK-1 signaling pathway[J/OL]. Phytomedicine, 2022, 104: 154140. DOI: 10.1016/j.phymed.2022.154140.
[52]
Ma XN, Feng W, Li N, et al. Leonurine alleviates rheumatoid arthritis by regulating the Hippo signaling pathway[J/OL]. Phytomedicine, 2024, 123: 155243. DOI: 10.1016/j.phymed.2023.155243.
[1] 张霞, 冯娅娆, 罗寰, 杨金良, 张斌, 郑学军. 尪痹胶囊联合来氟米特对类风湿关节炎炎症指标的影响[J/OL]. 中华关节外科杂志(电子版), 2025, 19(01): 55-64.
[2] 刘鹏, 罗天, 许珂媛, 邓红美, 李瑄, 唐翠萍. 八段锦对膝关节炎疗效的初步步态分析[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 590-595.
[3] 王帆, 余辉, 谢佳乐, 许焕焕, 马瑞, 依日夏提·艾海提, 许珂, 许鹏. 成纤维样滑膜细胞在类风湿关节炎发病机制中的作用[J/OL]. 中华关节外科杂志(电子版), 2024, 18(02): 225-230.
[4] 陈晓霞, 钟文素, 郑宝群. 声触诊组织成像量化技术评估类风湿关节炎活动性[J/OL]. 中华关节外科杂志(电子版), 2024, 18(01): 54-59.
[5] 张子远, 姜笃银. 基于网络药理学和分子对接探讨沙棘促进烧烫伤创面修复的作用机制[J/OL]. 中华损伤与修复杂志(电子版), 2025, 20(05): 404-411.
[6] 张可颖, 冀雨薇, 付章宁, 张益帆, 王晓晨, 杨滟, 陈香美, 蔡广研, 洪权. 人参皂苷Rb1 预处理间充质干细胞的转录组分析及急性肾损伤治疗关键基因挖掘[J/OL]. 中华肾病研究电子杂志, 2025, 14(01): 26-33.
[7] 俞俊霞, 台宗光, 程婷婷, 朱全刚. 红花平疣颗粒治疗扁平疣的网络药理学分析及羟基红花黄色素A的含量测定[J/OL]. 中华临床医师杂志(电子版), 2023, 17(12): 1270-1276.
[8] 王鹏飞, 孙逸旸, 于岩瀑, 高树中. 高树中教授脐疗理论与临床应用[J/OL]. 中华针灸电子杂志, 2025, 14(04): 157-160.
[9] 马新童, 马铁明. 马铁明教授针药结合治疗偏头痛临床经验撷菁[J/OL]. 中华针灸电子杂志, 2025, 14(03): 111-114.
[10] 代培森, 郭东升, 张超, 刘爱峰, 薛宏飞, 王培检, 李文达, 高揆量. 针药并用治疗膝骨关节炎的研究进展[J/OL]. 中华针灸电子杂志, 2025, 14(03): 104-106.
[11] 尹巧英, 钱雅妮, 雷慧恩, 王石柳, 李婷婷, 尹瑞华, 卢璐. 针药结合治疗痰湿型多囊卵巢综合征肥胖:随机对照试验[J/OL]. 中华针灸电子杂志, 2025, 14(03): 99-103.
[12] 张艳军. 针药并用的科学内涵与临床价值:机制创新与重大疾病防治的新路径[J/OL]. 中华针灸电子杂志, 2025, 14(03): 94-98.
[13] 程海波. 慢病防控视角下的“针药结合、增效减药”理念探讨[J/OL]. 中华针灸电子杂志, 2025, 14(03): 89-93.
[14] 李军. "调神大法"治疗和干预围绝经期综合征[J/OL]. 中华针灸电子杂志, 2024, 13(02): 56-57.
[15] 孙攀喜, 魏丽丽, 陈勇, 樊东升. 王不留行黄酮苷对小鼠缺血性脑损伤的影响[J/OL]. 中华脑血管病杂志(电子版), 2025, 19(03): 220-227.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?